Interphase Cytogenetic Analysis of Prostatic Carcinomas by Use of Nonisotopic in Situ Hybridization

Cancer Research

Volumn 54, Issue 16, 1994, Pages 4472-4480

  Baretton, Gustavo Bruno ^a   Valina, Christian ^a   Vogt, Thomas ^a   Schneiderbanger, Karin ^a   Diebold, Joachim ^a   Löhrs, Udo ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER GRADING; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA PROBE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INTERPHASE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

AGED; CHROMOSOME ABERRATIONS; DNA PROBES; FLOW CYTOMETRY; HUMAN; IN SITU HYBRIDIZATION; INTERPHASE; MALE; PLOIDIES; PROSTATE; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; X CHROMOSOME; Y CHROMOSOME;

EID: 0028023024     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Dhom, G. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J. Cancer Res. Clin. Oncol., 106: 210-218, 1983.
2. Deitch, A.D., and deVere White, R.W. Flow cytometry as a predictive modality in prostate cancer. Hum. Pathol., 23: 352-359, 1992.
3. Lieber, M.M. Prostatic dysplasia: significance in relation to nuclear DNA ploidy studies of prostate adenocarcinoma. Urology, 34(Suppl.): 43-48, 1989.
4. Frankfurt, O.S., Chin, J.L., Englander, L.S., Greco, W.R., Pontes, J.E., and Rustum, Y.M. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Cancer Res., 45: 1418-1423, 1985.
5. Forsslund, G., Esposti, P.L., Nilsson, B., and Zetterberg, A. The prognostic significance of nuclear DNA content in prostatic carcinoma. Cancer (Phila.), 69: 1432-1439, 1992.
6. Tavarres, A.S., Costa, J., and Maia, J.C. Correlation between ploidy and prognosis in prostate carcinoma. J. Urol., 109: 676-679, 1973.
7. Sandberg, A.A. Chromosomal abnormalities and related events in prostate cancer. Hum. Pathol., 23: 368-380, 1992.
8. Brothman, A.R., Peehl, D.M., Patel, A.M., and McNeal, J.E. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res., SO: 3795-3803, 1990.
9. Lundgren, R., Heim, S., Mandahl, N., Anderson, H., and Mitelman, F. Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients. J. Urol., 147: 784-788, 1992.
10. Breitkreuz, T., Romanakis, K., Lutz, S., Seitz, G., Bonkhoff, H., Unteregger, G., Zwergel, T., Zang, K.D., and Wullich, B. Genotypic characterization of prostatic carcinomas: a combined cytogenetic flow cytometry and in situ DNA hybridization study. Cancer Res., 53: 4035-4040, 1993.
11. Weinberg, R.A. Oncogenes antioncogenes and the molecular bases of multistep carcinogenesis. Cancer Res., 49: 3713-3721, 1989.
12. Hopman, A.H., van Hooren, E., van de Kaa, C.A., Vooijs, P.G., and Ramaekers, F.C. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod. Pathol., 4: 503-513, 1991.
13. Poddighe, P.J., Ramaekers, F.C., and Hopman, A.H. Interphase cytogenetics of tumours. J. Pathol., 166: 215-224, 1992.
14. Arnoldus, E.P., Dreef, E.J., Noordermeer, I.A., Verheggen, M.M., Thierry, R.F., Peters, A.C., Cornelisse, C.J., Van der Ploeg, M., and Raap, A.K. Feasibility of in situ hybridisation with chromosome specific DNA probes on paraffin was embedded tissue. J. Clin. Pathol. (Lond.), 44: 900-904, 1991.
15. van Dekken, H., Pizzolo, J.G., Reuter, V.E., and Melamed, M.R. Cytogenetic analysis of human solid tumors by in situ hybridization with a set of 12 chromosome-specific DNA probes. Cytogenet. Cell Genet., 54: 103-107, 1990.
16. Persons, D.L., Gibney, D.J., Katzmann, J.A., Lieber, M.M., Farrow, G.M., and Jenkins, R.B. Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma. J. Urol., 150: 120-125, 1993.
17. Henke, R.P., Krüger, E., Ayhan, N., Hübner, D., and Hammerer, P. Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kinetics. Virchows Arch. A Pathol. Anat. Histopathol., 422: 61-66, 1993.
18. Gleason, D.F., and Mellinger, G.I. Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging. J. Urol., 111: 58-64, 1974.
19. Helpap, B., Böcking, A., Dhom, G., Faul, P., Kastendieck, H., Leistenschneider, W., and Müller, H.A. Klassifikation, histologisches und zytologisches Grading sowie Regressionsgrading des Prostatakarzinoms. Eine Empfehlung des Pathologisch-Urologischen Arbeitskreises “Prostatakarzinom”. Pathologe, 6: 3-7, 1985.
20. Hopman, A.N.H., Ramaekers, F.C.S., and Vooijs, G.P. Interphase cytogenetics of solid tumours. In: J.M. Polak and J.O. McGee (eds.), In Situ Hybridization: Principles and Practice, pp. 165-186. Oxford: Oxford University Press, 1989.
21. Stock, C., Ambros, I.M., Mann, G., Gadner, H., Amann, G., and Ambros, P.F. Detection of lp. 6 deletions in paraffin sections of neuroblastoma tissues. Genes Chromosomes Cancer, 6: 1-9, 1993.
22. Hedley, D.W., Friedlander, M.L., Taylor, I.W., Rugg, C.A., and Musgrove, E.A. Method for analysis of cellular DNA-content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem., 31: 1333-1335, 1983.
23. Baretton, G., Dicbold, J., DePascale, T., Bussar-Maatz, R., Weissbach, L., and Löhrs, U. DNA-ploidy in seminomas with and without syncytiotrophoblastic cells. A flow and image cytometric study. J. Urol., 757: 67-71, 1994.
24. Ljungberg, B., Forsslund, G., Stenling, R., and Zetterberg, A. Prognostic significance of the DNA content in renal cell carcinoma. J. Urol., 735: 422-427, 1986.
25. Hopman, A.H., Moesker, O., Smeets, A.W., Pauwels, R.P., Vooijs, G.P., and Ramaekers, F.C. Numerical chromosome 1, 7,9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res., 57: 644-651, 1991.
26. Waldman, F.M., Carroll, P.R., Kerschmann, R., Cohen, M.B., Field, F.G., and Mayall, B.H. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res., 57: 3807-3810, 1991.
27. van Dekken, H., Pizzolo, J.G., Kelsen, D.P., and Melamed, M.R. Targeted cytogenetic analysis of gastric tumors by in situ hybridization with a set of chromosome-specific DNA probes. Cancer (Phila.), 66: 491-497, 1990.
28. Devilee, P., Thierry, R.F., Kievits, T., Kolluri, R., Hopman, A.N.H., Willard, H.F., Pearson, P.L., and Cornelisse, C.J. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res., 48: 5825-5830, 1988.
29. Giwercman, A., Hopman, A.H., Ramaekers, F.C., and Skakkebaek, N.E. Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization. Am. J. Pathol., 136: 497-502, 1990.
30. Arnoldus, E.P.J., Noordermeer, I.A., Peters, A.C.B., Voormolen, J.H.C., Bots, G.T.A.M., Raap, A.K., and Van der Ploeg, M. Interphase cytogenetics of brain tumors. Genes Chromosomes Cancer, 3: 101-108, 1991.
31. van de Kaa, C.A., Nelson, K.A.M., Ramaekers, F.C.S., Vooijs, G.P., and Hopman, A H.N. Interphase cytogenetics in paraffin sections of routinely processed hydatidiform moles and hydropic abortions. J. Pathol., 765: 281-287, 1991.
32. van Dekken, H., and Alers, J. Loss of chromosome Y in prostatic cancer cells but not in stromal tissue. Cancer Genet. Cytogenet., 66: 131-132, 1993.
33. Carter, B.S., Ewing, C.M., Ward, W.S., Treiger, B.F., Aalders, T.W., and Schalken, J.A. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
34. Bergerheim, U.S.R., Kunimi, K., Collins, V.P., and Ekman, P. Deletion mapping of chromosomes 8, 10, and 16 in human prostate carcinoma. Genes Chromosomes Cancer, 3: 215-220, 1991.
35. Miller, C., Mohandas, T., Wolf, D., Prococimer, M., Rolier, V., and Koeffler, H.P. Human p. 3 gene is localised to the short arm of chromosome 17. Nature (Lond.), 319: 783-785, 1986.
36. Macoska, J.A., Powell, I.J., Sakr, W., and Lane, M.A. Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. J. Urol., 147: 1142-1146, 1992.
37. Bookstein, R., and Allred, D.C. Recessive oncogenes. Cancer (Phila.), 71: 1179-1186, 1993.
38. Fukushige, S., Matsubara, K., Yoshida, M., Sasaki, M., Suzuki, T., Semba, JC, Toyoshima, K., and Yamamoto, T. Localization of a novel v-erbB-2 related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol. Cell. Biol., 6: 955-958, 1986.
39. Cunha, G.R., Donjaious, A.A., and Cooke, P.S. The endocrinology and developmental biology of the prostate. Endocr. Rev., 8: 338-352, 1987.
40. Darbre, P.D., and King, R.J.B. Progression to steroid insensivity can occur irrespective of the presence of functional steroid receptors. Cell, 51: 521-528, 1987.
41. König, J.J., Kamst, E., Hagemeijer, A., Romijn, J.C., Horoszewicz, J., and Schröder, F.H. Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP. Urol. Res., 17: 79-86, 1989.
42. Lubahn, D.B., Joseph, D.R., Sullivan, P.M., Willard, H.F., French, F.S., and Wilson, E.M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science (Washington DC), 240: 327, 1988.
43. Grayhack, J.T., and Assimos, D.G. Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate. Prostate, 4: 13-31, 1983.
44. Chodak, G.W., Thisted, R.A., Gerber, G.S., Johansson, J.E., Adolfsson, J., Jones, G.W., Chisholm, G.D., Moskovitz, B., Livne, P.M., and Warner, J. Results of conservative management of clinically localized prostate cancer. N. Engl. J. Med., 330: 242-248, 1994.
45. Baretton, G., Vogt, T., Blasenbreu, S., and Löhrs, U. Comparison of DNA ploidy in prostatic intraepithelial neoplasia (PIN) and invasive carcinoma of the prostate. Hum. Pathol., 25: 506-513, 1994.
46. Koss, L.G., Czerniak, B., Herz, F., and Wersto, R.P. Flow cytometric measurements of DNA and other cell components in human tumors a critical appraisal. Hum. Pathol., 20: 528-548, 1989.